NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Prous Institute for Biomedical Research

Prous Institute for Biomedical Research

Overview

Prous Institute for Biomedical Research is a Spanish research and investment firm that partners with and invests in early-stage biomedical projects, including therapeutics, diagnostics, artificial intelligence, and digital health sectors.

Year Founded

2000

Portfolio Companies

4

Investments

Prous Institute for Biomedical Research investments
CompanyDateStageLead
Nanobots TherapeuticsDec 2024SeedCo-investor
Nanobots TherapeuticsSep 2023Pre SeedCo-investor
FollowApp CareJan 2023SeedLead
Connecta TherapeuticsSep 2020SeedCo-investor
MedBioinformatics Solutions SLFeb 2020SeedCo-investor

Key People

David Prous

Co-Founder Executive Director

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Unlock portfolio analytics

Sign up to view full sector, stage, and valuation breakdowns for this investor.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Unlock portfolio analytics

Sign up to explore yearly investment trends and funding raised over time.

FAQ

Firmographic Details

HeadquartersBarcelona
Year Founded2000

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.